HT BioImaging provides a medical imaging platform technology designed for early, on-the-spot cancer detection and classification. The company is the developer of the heat diffusion imaging (HDI) scan, a disruptive system to measure heat diffusion in biological tissues. This new medical imaging technology translates the heat diffusion signal into an image to enable early detection of cancer in a noninvasive and real-time procedure at the point of care and in operating rooms.
Cumulative Funding Raised Over Time ($)
Employees Over Time
HT BioImaging Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Mar 22, 2022
www.businesswire.com
Companion Animal Health Announces Strategic Investment in Early Cancer Detection Solution